Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
CEN Case Reports
Literature
1.
Nakazawa E, Uchimura T, Hirai Y, et al. New-onset pediatric nephrotic syndrome following Pfizer-BioNTech SARS-CoV-2 vaccination: a case report and literature review [published online ahead of print, 2021 Nov 15]. CEN Case Rep. 2021;1–5.
2.
Miyasaka M. COVID-19 and immunity: quo vadis? Int Immunol. 2021;33(10):507–13.CrossRef
3.
Sahin U, Muik A, Vogler I, et al. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature. 2021;595(7868):572–7.CrossRef
4.
Abeyagunawardena AS, Goldblatt D, Andrews N, Trompeter RS. Risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome. Lancet. 2003;362:449–50.CrossRef
Metadata
Title
A young adult with nephrotic syndrome following COVID-19 vaccination
Authors
Kei Nagai
Mikiko Kageyama
Mamiko Iwase
Atsushi Ueda
Publication date
04-01-2022
Publisher
Springer Nature Singapore
Published in
CEN Case Reports / Issue 3/2022
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-021-00673-z

Other articles of this Issue 3/2022

CEN Case Reports 3/2022 Go to the issue

Case Report

Proliferative glomerulonephritis with monoclonal immunoglobulin deposits triggered by COVID-19: a case report

Case Report

An adolescent girl diagnosed with IgA nephropathy following the first dose of the COVID-19 vaccine

Case Report

Involvement of neutrophil extracellular traps in the pathogenesis of glomerulonephritis in a case of systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis overlap syndrome

Case Report

A case of Wernicke encephalopathy arising in the early stage after the start of hemodialysis

Case Report

Atypical manifestations of infantile-onset nephropathic cystinosis: a diagnostic challenge

Case Report

Influenza-induced thrombotic microangiopathy in a patient with cancer on proteasome inhibitor: a diagnostic dilemma
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits